Key Metrics
CiteScore 

4.8
Impact Factor 

< 5
SJR 

Q1Ophthalmology

SNIP 

1.7
Recommended pre-submission checks
Powered by 

Topics Covered on Ophthalmology and Therapy
Ophthalmology and Therapy Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
DOAJ
SJR
| Overview | |
| Publisher | SPRINGER INT PUBL AG |
| Language | English |
| Frequency | Semi-annual |
| Article Processing Charges | EUR 5500 | USD 6850 | GBP 4700 |
| Publication Time | 6 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Semi-annual |
| Publication Start Year | 2012 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Publication Time | 6 |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in Ophthalmology and Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Ophthalmology and Therapy
Summary of Research: Economic Benefit of Aflibercept 8mg Versus Faricimab for Neovascular Age-Related Macular Degeneration or Diabetic Macular Edema in the US.
- 20 May 2026
- Ophthalmology and therapy
Half-Dose Photodynamic Therapy for Bullous Variant Central Serous Chorioretinopathy: A Long-Term Follow-Up.
- 19 May 2026
- Ophthalmology and therapy
Prospective Real-World Outcomes After Switching to Aflibercept 8mg in Neovascular Age-Related Macular Degeneration with High Treatment Burden.
- 19 May 2026
- Ophthalmology and therapy
The Role of Sex in Ocular Biometry: A Large-Scale Study of Cataract Candidates in Greece.
- 16 May 2026
- Ophthalmology and therapy
Treatment Persistence with Combination Eye Drops for Glaucoma: A Longitudinal Analysis Using Japanese Medical Claims Data.
- 15 May 2026
- Ophthalmology and therapy
A Multicenter, Real-World Experience with Polyhexamethylene Biguanide (PHMB) 0.08% Monotherapy for Treating Acanthamoeba Keratitis: A Retrospective Review of 39 Cases.
- 15 May 2026
- Ophthalmology and therapy
Summary of Research: Economic Benefit of Aflibercept 8mg Versus Faricimab for Neovascular Age-Related Macular Degeneration or Diabetic Macular Edema in the US.
- 20 May 2026
- Ophthalmology and therapy
Half-Dose Photodynamic Therapy for Bullous Variant Central Serous Chorioretinopathy: A Long-Term Follow-Up.
- 19 May 2026
- Ophthalmology and therapy
Prospective Real-World Outcomes After Switching to Aflibercept 8mg in Neovascular Age-Related Macular Degeneration with High Treatment Burden.
- 19 May 2026
- Ophthalmology and therapy
The Role of Sex in Ocular Biometry: A Large-Scale Study of Cataract Candidates in Greece.
- 16 May 2026
- Ophthalmology and therapy
Treatment Persistence with Combination Eye Drops for Glaucoma: A Longitudinal Analysis Using Japanese Medical Claims Data.
- 15 May 2026
- Ophthalmology and therapy
A Multicenter, Real-World Experience with Polyhexamethylene Biguanide (PHMB) 0.08% Monotherapy for Treating Acanthamoeba Keratitis: A Retrospective Review of 39 Cases.
- 15 May 2026
- Ophthalmology and therapy